Amicus Therapeutics, Inc.
Pharmaceutical company · Princeton, New Jersey, United States
Amicus Therapeutics, Inc. is a pharmaceutical company headquartered in Princeton, New Jersey, United States. It has reported private securities offerings to the US SEC, most recently $30 million sold in a notice filed in 2023.
Profile compiled from public records. Is this your company? Request a correction or update
Amicus Therapeutics at a glance
Typepharmaceutical company
HeadquartersPrinceton, New Jersey, United States
SEC industryPharmaceutical Preparations
SEC CIK1178879
What does Amicus Therapeutics do?
Private fundraising reported to the SEC
7 Form D notices; the most recent reported $30 million sold (2023).
Frequently asked questions about Amicus Therapeutics
Where is Amicus Therapeutics headquartered?
Amicus Therapeutics, Inc. is headquartered in Princeton, New Jersey, United States.
What does Amicus Therapeutics do?
Amicus Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Similar companies
- Soligenix, Inc.Princeton, New Jersey, United States
- PDS Biotechnology CorpPrinceton, New Jersey, United States
- Enalare Therapeutics Inc.Princeton, New Jersey, United States
- Bristol Myers Squibb CoPrinceton, New Jersey, United States
- Grace Therapeutics, Inc.Princeton, New Jersey, United States
- PMV Pharmaceuticals, Inc.Princeton, New Jersey, United States
- Church & Dwight Co., Inc.Princeton, New Jersey, United States
- Agile Therapeutics IncPrinceton, New Jersey, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-24. Data licences